Literature DB >> 19880991

[Progress of research in osteoarthritis. Metalloproteinases in osteoarthritis].

Aiko Okada1, Yasunori Okada.   

Abstract

Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage induced by accumulated mechanical stresses to joints. Destruction of the articular cartilage in OA is caused by the combination of (1) increased degradation of ECM (extracellular matrix), (2) decreased production of ECM and (3) chondrocyte death. Members of the MMP (matrix metalloproteinase) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) gene families are considered to play key roles in the degradation of cartilage ECM. On the other hand, members of the membrane-type ADAM gene family may be involved in the initiation and progression of OA by regulation of chondrocyte metabolism through shedding of membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880991     DOI: CliCa091115931601

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  9 in total

1.  The evaluation of the effectiveness of intra-articular steroid, tenoxicam, and combined steroid-tenoxicam injections in the treatment of patients with knee osteoarthritis.

Authors:  Ebru Yilmaz
Journal:  Clin Rheumatol       Date:  2019-06-26       Impact factor: 2.980

Review 2.  Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.

Authors:  Charles A Galea; Hai M Nguyen; K George Chandy; Brian J Smith; Raymond S Norton
Journal:  Cell Mol Life Sci       Date:  2013-08-03       Impact factor: 9.261

3.  Intracellular trafficking of the KV1.3 potassium channel is regulated by the prodomain of a matrix metalloprotease.

Authors:  Hai M Nguyen; Charles A Galea; Galina Schmunk; Brian J Smith; Robert A Edwards; Raymond S Norton; K George Chandy
Journal:  J Biol Chem       Date:  2013-01-08       Impact factor: 5.157

Review 4.  Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid.

Authors:  Tommaso Iannitti; Daniele Lodi; Beniamino Palmieri
Journal:  Drugs R D       Date:  2011

5.  Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac.

Authors:  Keiji Yoshioka; Tomochika Kisukeda; Ryoji Zuinen; Yosuke Yasuda; Kenji Miyamoto
Journal:  BMC Musculoskelet Disord       Date:  2018-05-22       Impact factor: 2.362

Review 6.  LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis.

Authors:  Ying Zhang; Fuyou Wang; Guangxing Chen; Rui He; Liu Yang
Journal:  Cell Biosci       Date:  2019-07-01       Impact factor: 7.133

7.  Calcium-binding protein 39 overexpression promotes macrophages from 'M1' into 'M2' phenotype and improves chondrocyte damage in osteoarthritis by activating the AMP-activated protein kinase/sirtuin 1 axis.

Authors:  Qiuliang Liu; Kai Pian; Zhen Tian; Haitao Duan; Qi Wang; Hui Zhang; Longyan Shi; Dongjian Song
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  Circ_0045714 alleviates TNF-α-induced chondrocyte injury and extracellular matrix degradation through miR-218-5p/HRAS axis.

Authors:  Haitao Jiang; Jian Dai; Cheng Zhang; Hailang Sun; Xiaoming Tang
Journal:  J Bioenerg Biomembr       Date:  2021-01-04       Impact factor: 2.945

9.  Activation of α2A-adrenergic signal transduction in chondrocytes promotes degenerative remodelling of temporomandibular joint.

Authors:  Kai Jiao; Guang Zeng; Li-Na Niu; Hong-Xu Yang; Gao-Tong Ren; Xin-Yue Xu; Fei-Fei Li; Franklin R Tay; Mei-Qing Wang
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.